A hypogammaglobulinaemic man with respiratory failure.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2360881)

Published in Postgrad Med J on August 01, 1998

Authors

W A Sewell1, S E Marshall, C G Mullighan, A G Bird

Author Affiliations

1: Department of Clinical Immunology, Royal Free Hospital, London, UK.

Articles by these authors

No escape: HIV transmission in jail. BMJ (1993) 3.91

Revised guidelines for HIV infected health care workers. BMJ (1993) 3.16

Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ (1995) 2.66

Inside methodology: HIV surveillance in prisons. AIDS (1994) 2.39

Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10

Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03

Uptake of confidential, named HIV testing in Scottish prisons. Lancet (1992) 2.01

Prisoners' uptake of confidential, named HIV testing. Lancet (1992) 1.99

A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev (1979) 1.91

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77

Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis. Lancet (1987) 1.61

A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60

A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol (1979) 1.54

No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49

Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. Int J STD AIDS (1997) 1.48

Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM (1999) 1.47

Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur J Clin Invest (2000) 1.46

Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42

Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis (1991) 1.40

Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39

Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology (1979) 1.39

Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39

A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res (2000) 1.37

Increased expression of the CD45RO (memory) antigen on T cells in HIV-infected children. AIDS (1991) 1.37

Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11. Oncogene (2007) 1.35

Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol (2002) 1.35

The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods (1984) 1.21

Mannose-binding lectin: biology and clinical implications. Intern Med J (2005) 1.17

Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics (2000) 1.16

X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15

Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun (1999) 1.15

The multiple complexes formed by the interaction of platelet factor 4 with heparin. Biochem J (1980) 1.13

Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS (1996) 1.11

Second anonymous HIV surveillance in Saughton Prison, Edinburgh: prisoners give a lead to other heterosexuals on being HIV tested. AIDS (1993) 1.10

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol (2014) 1.08

IDH1 and IDH2 mutations in pediatric acute leukemia. Leukemia (2011) 1.08

Donor-specific bone marrow and long-term survival of allogeneic arm transplant. Lancet (1999) 1.08

Role of Ca2+ ions in the regulation of intramitochondrial metabolism in rat epididymal adipose tissue. Evidence against a role for Ca2+ in the activation of pyruvate dehydrogenase by insulin. Biochem J (1984) 1.06

Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev (1981) 1.05

Drugs in British prisons. Policies need outside scrutiny if they are to do more good than harm. BMJ (1998) 1.05

Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med (1990) 1.04

Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J (1992) 1.02

Persistence of the effect of insulin on pyruvate dehydrogenase activity in rat white and brown adipose tissue during the preparation and subsequent incubation of mitochondria. Biochem J (1984) 1.01

Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99

Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol (2000) 0.99

Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS (1994) 0.99

High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens (2002) 0.99

The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant (1993) 0.98

Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood (1980) 0.97

Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol (1986) 0.96

Genomic profiling of high-risk acute lymphoblastic leukemia. Leukemia (2010) 0.96

Method used to identify previously undiagnosed infections in the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.96

Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol (1994) 0.95

Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med (1993) 0.94

Transmission of HIV in prison. BMJ (1993) 0.93

Glucose-6-phosphate isomerase. Philos Trans R Soc Lond B Biol Sci (1981) 0.93

Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens (2007) 0.93

Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene (2011) 0.93

Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion. Leukemia (2011) 0.93

T cell regulation in adult transplantation tolerance. J Immunol (1996) 0.93

Human cytomegalovirus infection is not increased in common variable immunodeficiency. J Clin Immunol (1996) 0.92

The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens (2003) 0.92

CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr AIDS HIV Infect (1996) 0.91

Prison rights: mandatory drugs tests and performance indicators for prisons. BMJ (1996) 0.91

Mitogenic activation of human lymphocytes: a protein A plaque assay evaluation of polyclonal B-cell activators. Scand J Immunol (1980) 0.90

Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab (2000) 0.90

Mandatory drug tests in prisons. BMJ (1995) 0.90

Lipopolysaccharide and lipid A-induced human blood lymphocyte activation as detected by a protein A plaque assay. Eur J Immunol (1979) 0.89

Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int (1999) 0.89

Benefits of HIV antibody testing in symptom-free risk groups. Lancet (1989) 0.89

Study size and documentation to detect injection-related hepatitis C in prison. QJM (1998) 0.89

The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant (1993) 0.89

Cyclosporin A and Epstein-Barr virus. Lancet (1980) 0.88

Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun (1999) 0.87

Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity. Clin Exp Immunol (1993) 0.87

CARD15 polymorphisms in Behçet's disease. Scand J Rheumatol (2005) 0.87

Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children. J Clin Immunol (1994) 0.86

Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol (Oxf) (2001) 0.86

Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Ann Intern Med (1990) 0.86

Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte. Clin Exp Immunol (1981) 0.86

Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B. J Immunol Methods (2000) 0.86

Occupational asthma due to sodium iso-nonanoyl oxybenzene sulphonate, a newly developed detergent ingredient. Thorax (1988) 0.85

Concorde trial of immediate versus deferred zidovudine. Lancet (1994) 0.85

The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension. Transplant Proc (1991) 0.85

A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population. Gut (1998) 0.85

Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B, and Fas ligand fine-needle aspiration immunocytology. Transplantation (2000) 0.84

AIDS encephalopathy with response to treatment. Arch Dis Child (1988) 0.84

HLA class I, II & III genes in confirmed late-onset Alzheimer's disease. Neurobiol Aging (2001) 0.84

Pulmonary haemosiderosis and gluten. Arch Dis Child (1987) 0.83

Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression. Transplant Proc (2005) 0.83

Prison rites: starting to inject inside. BMJ (1995) 0.83

Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease. Gastroenterology (1978) 0.83

Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin Exp Immunol (2001) 0.82

B cell differentiation and lymphocyte surface phenotype in late onset hypogammaglobulinaemia. Dis Markers (1990) 0.82

The Edinburgh City Hospital cohort: analysis of enrollment, progression and mortality by baseline covariates. QJM (1995) 0.82

A combination of molecular and morphological approaches resolves species in the taxonomically difficult genus Procladius Skuse (Diptera: Chironomidae) despite high intra-specific morphological variation. Bull Entomol Res (2011) 0.82

Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation. J Heart Lung Transplant (1991) 0.81